Recent epidemiological data indicates that over 3 million children under the age of 5 are hospitalized due to RSV-related infections each year, with over 200,000 deaths annually.

Aragen Bioscience offers a wide range of customized and high quality pre-clinical animal models and ex vivo readouts to support anti-RSV biologics development from concept all the way to IND. 

Download our Whitepaper to understand how our expert and experienced staff provides scientific input and support for all project stages in addition to antibody development, characterization and determination of functional activity in vitro and in vivo

In Vivo Models & In Vitro Assays for Human RSV Infection -
Pre-Clinical Antibody, Small Molecule & Vaccine Development

© 2019 GVK Biosciences Private Limited. All Rights Reserved
Terms & ConditionsPrivacy Policy | Privacy Notice - Customers/Vendors/Job Applicants

Please complete the form to download